| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.23B | +5.6% | +22.2% |
| Cost of Revenue | $307.8M | -0.8% | +20.7% |
| Gross Profit | $926.4M | +7.9% | +22.7% |
| R&D Expense | $347.6M | +0.3% | +26.1% |
| SG&A Expense | $167.3M | -6.0% | +31.8% |
| Operating Income | -$69.4M | +38.5% | -24.6% |
| Pre-tax Income | -$23.3M | +67.5% | -120.8% |
| Income Tax | $10.7M | +79.5% | +70.7% |
| Net Income | -$34.0M | +56.2% | -102.1% |
| EPS (Basic) | -$0.14 | +54.8% | -100.0% |
| EPS (Diluted) | -$0.14 | +54.8% | -100.0% |
| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $4.80B | -3.4% | +12.7% |
| Accounts Receivable | $1.01B | +14.3% | +24.5% |
| Current Assets | $6.52B | -0.2% | +17.0% |
| Total Assets | $9.97B | +7.3% | +28.0% |
| Current Liabilities | $3.60B | +3.6% | +20.0% |
| Long-term Debt | $745.1M |
| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $1.11B | — | — |
| Capital Expenditures | $199.6M | — | — |
| Investing Cash Flow | -$641.5M | — | — |
| Financing Cash Flow | $81.1M | — | — |
| Free Cash Flow | $914.8M | — | — |
| +0.2% |
| Total Liabilities | $5.91B | +7.5% | +26.0% |
| Stockholders' Equity | $4.02B | +6.9% | +31.3% |